The results of a recent phase II study evaluating 160 patients with active Crohn’s disease, with a high dose of mongersen were recently published. The study demonstrated a statistically significant remission rate of 65% compared to 9.5% for a placebo, measured after two weeks of treatment. Learn more here: http://thegiconnection.com/new-oral-therapy-for-crohns-disease-appears-promising/
Interested in more discussions like this? Go to the National Crohn's/Ulcerative Colitis Support Group group.
Has anyone been on a clinical trial evaluating mongersen? Share your experience!